Effect of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on liver fibrosis

Authors :: Hideto Kawaratani
Shinya Sato
Takemi Akahane
Takuya Kubo
Yasuhiko Sawada
Tadashi Namisaki
Hiroaki Takaya
Kei Moriya
Yasushi Okura
Masanori Furukawa
N. Nishimura
Soichiro Saikawa
Naotaka Shimozato
Kenichiro Seki
Mitsuteru Kitade
Hitoshi Yoshiji
K. Kaji
Source :: Journal of Hepatology. 68:S335-S336
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Agonist
Hepatology
medicine.drug_class
Chemistry
Liver fibrosis
Sitagliptin
medicine
Farnesoid X receptor
Dipeptidyl peptidase-4 inhibitor
Pharmacology
medicine.drug

Full Text Access

Tools